NeurologyLive® Mind Moments®

127 - 114: Phase 3 PHOENIX Study, AMX0035, and Amylyx's Future Drug Development

Mind Moments®, a podcast from NeurologyLive® (https://www.neurologylive.com/) , brings you exclusive interviews with experts in neurologic disorders. Listen in to hear the latest clinical and research updates from major medical conferences, as well as insights on the management of complex disorders, including epilepsy, migraine, Alzheimer disease, stroke, multiple sclerosis, Parkinson disease, and more. For more expert insight into neurology, visit NeurologyLive.com (https://www.neurologylive.com/) .

Другие подкасты - %(genre)s

127 - 114: Phase 3 PHOENIX Study, AMX0035, and Amylyx's Future Drug Development

Fri, 03 May 2024
126 - Special Episode: FDA Approval of Diazepam Buccal Film for Pediatric Seizures

Wed, 01 May 2024
125 - 113: Lessons Learned in Alzheimer Drug Development

Fri, 19 Apr 2024
124 - 112: Exploring Dimethyl Fumarate to Treat Friedreich Ataxia

Fri, 05 Apr 2024
123 - Special Episode: FDA Approval of Givinostat for Duchenne Muscular Dystrophy

Fri, 29 Mar 2024
122 - 111: Reviewing ACTRIMS 2024

Fri, 22 Mar 2024
121 - 110: Differential Diagnosis of Sleep Disorders and Hypersomnias

Fri, 08 Mar 2024
120 - 109: AB126, Exosomes, and Cerebroprotection for Stroke

Fri, 23 Feb 2024
119 - 108: Advancing the Genetic Pool of Parkinson Disease

Fri, 09 Feb 2024
118 - 107: Revealing Mechanisms of Sudden Unexplained Death in Toddlers

Fri, 26 Jan 2024
117 - 106: Potential Role of Stathmin-2 in Amyotrophic Lateral Sclerosis

Fri, 12 Jan 2024
116 - 105: Recapping Conversations in Neurology From 2023

Fri, 29 Dec 2023
115 - 104: Effects of Once-Nightly Sodium Oxybate on Narcolepsy Type 1 and 2

Fri, 15 Dec 2023
114 - 103: Advancing Epilepsy Care and Seizure Localization in Pediatrics

Fri, 01 Dec 2023
113 - 102: Potential of Gamma Sensory Stimulation in Alzheimer Disease

Fri, 17 Nov 2023
112 - Special Episode: FDA Greenlights Vamorolone for Duchenne Muscular Dystrophy

Tue, 07 Nov 2023
111 - 101: Ways to Enhance Neuromodulation in Parkinsonism

Fri, 03 Nov 2023
110 - Special Episode: FDA Approves Zilucoplan for Myasthenia Gravis

Mon, 23 Oct 2023
109 - 100: 2023 ECTRIMS-ACTRIMS Meeting Highlights

Fri, 20 Oct 2023
108 - 99: Understanding AMX0035's Potential in Progressive Supranuclear Palsy

Thu, 05 Oct 2023
107 - 98: Uncovering Phenotypical Features of Narcolepsy Type 1

Fri, 22 Sep 2023
106 - 97: Identifying Gaps in Access to Parkinson Disease Care

Fri, 08 Sep 2023
105 - 96: Complexities With Cognitive Screening in Primary Care Settings

Fri, 25 Aug 2023
104 - Special Episode: Addition of Valbenazine to Treat Huntington Disease Chorea

Mon, 21 Aug 2023
103 - 95: Expanding Potential for Long-Term Treatment in SMA

Fri, 11 Aug 2023
102 - 94: The Discussion Surrounding Lecanemab's Approval for Alzheimer Disease

Fri, 28 Jul 2023
101 - 93: Caring for Women With Parkinson Disease

Fri, 14 Jul 2023
100 - 92: Highlights From the 2023 CMSC, SLEEP, AHS, and ATMRD Annual Meetings

Fri, 30 Jun 2023
99 - Special Episode: SRP-9001 Approved As First Gene Therapy for Duchenne Muscular Dystrophy

Thu, 22 Jun 2023
98 - 91: Assessing the Landscape of Sleep Disorder Care

Fri, 16 Jun 2023
97 - 90: Raising Stroke Awareness and Improving Clinical Care

Fri, 02 Jun 2023
96 - 89: Potential of CNM-Au8 Gold Nanocrystals to Treat ALS

Fri, 19 May 2023
95 - 88: 2023 AAN Annual Meeting Highlights

Fri, 05 May 2023
94 - Special Episode: Tofersen Approved for SOD1 ALS

Tue, 25 Apr 2023
93 - 87: Severe Multiple Sclerosis and the CASA-MS Study

Fri, 21 Apr 2023
92 - 86: Pimavanserin and Atypical Antipsychotics to Treat Parkinson Disease Psychosis

Fri, 07 Apr 2023
91 - 85: Impact of Narcolepsy on Social Relationship Health in Adolescents

Fri, 24 Mar 2023
90 - Special Episode: Trofinetide Approved for Rett Syndrome

Mon, 13 Mar 2023
89 - 84: Parkinson Disease Education for Community Providers

Fri, 10 Mar 2023
88 - 83: The ARISE Study and Using DMTs in RIS

Fri, 24 Feb 2023
87 - 82: Managing Seizures After Ischemic Stroke

Fri, 10 Feb 2023
86 - 81: Widening the Therapeutic Window in Parkinson Disease

Fri, 27 Jan 2023
85 - 80: Advancing Treatment for Rare Neuromuscular Disorders

Fri, 13 Jan 2023
84 - Special Episode: Lecanemab Approved for Alzheimer Disease

Mon, 09 Jan 2023
83 - 79: A New Monoclonal for Alzheimer Disease

Fri, 16 Dec 2022
82 - 78: A Virtual Reality Platform for Parkinson Disease

Fri, 02 Dec 2022
81 - 77: A New Era of Myasthenia Gravis Treatment

Fri, 18 Nov 2022
80 - 76: ECTRIMS 2022 and the Latest in MS Advances

Fri, 04 Nov 2022
79 - 75: Focusing on the Future of Neurology

Fri, 21 Oct 2022
78 - 74: Prescription Digital Therapeutics for Insomnia

Fri, 07 Oct 2022